Author

Laura Iliescu

REAL WORLD EFFICACY AND SAFETY OF SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION: A COHORT STUDY
REAL WORLD EFFICACY AND SAFETY OF SOFOSBUVIR/LEDIPASVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION: A COHORT STUDY

Laura Iliescu  et al.

RISK OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN 349 PATIENTS WITH LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION GENOTYPE 1 B TREATED WITH SOFOSBUVIR+LEDIPASVIR± RIBAVIRIN
RISK OF OCCURRENCE AND RECURRENCE OF HEPATOCELLULAR CARCINOMA IN 349 PATIENTS WITH LIVER CIRRHOSIS AND HEPATITIS C VIRUS INFECTION GENOTYPE 1 B TREATED WITH SOFOSBUVIR+LEDIPASVIR± RIBAVIRIN

Laura Iliescu  et al.

Item 1 - 2 / 2
1